Cargando…
Anticoagulation control among patients with nonvalvular atrial fibrillation: A single tertiary cardiac center experience
There is a limited knowledge about the predictors of anticoagulation control in patients with nonvalvular atrial fibrillation (NVAF). Furthermore, few reports addressed the role of time in therapeutic range (TTR) that could reflect the safety and efficacy of anticoagulation therapy. We aimed to asse...
Autores principales: | Mohammed, Shaban, Aljundi, Amer H. S., Kasem, Mohamed, Alhashemi, Mohammed, El-Menyar, Ayman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288964/ https://www.ncbi.nlm.nih.gov/pubmed/28217549 http://dx.doi.org/10.4103/2231-4040.197370 |
Ejemplares similares
-
Physician's Fear of Anticoagulant Therapy in Nonvalvular Atrial Fibrillation
por: Sen, Souvik, et al.
Publicado: (2014) -
Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy
por: Ferro, D., et al.
Publicado: (2007) -
Direct Oral Anticoagulants in Patients With Cancer and Nonvalvular Atrial Fibrillation
por: Davis, Margot K., et al.
Publicado: (2021) -
Laboratory Assessment of the Anticoagulant Activity of Apixaban in Patients
With Nonvalvular Atrial Fibrillation
por: Kyriakou, Elias, et al.
Publicado: (2018) -
Anticoagulants in Older Patients with Nonvalvular Atrial Fibrillation after Intracranial Hemorrhage
por: Perreault, Sylvie, et al.
Publicado: (2019)